Older Americans Quit Weight-Loss Drugs in Droves

Contributing sentiments towards policy:

56% : But to Bucklew's surprise, her Medicare Advantage plan covered it even though she wasn't diabetic, charging just a $25 monthly copay. Pizza, pasta, and red wine suddenly became unappealing.
55% : The Biden administration capped out-of-pocket payments for all prescriptions that a Medicare beneficiary receives ($2100 is the 2026 limit), and authorized annual price negotiations with manufacturers.
55% : Medicare Part D drug plans will then pay $274, and since most beneficiaries pay 25% in coinsurance, their out-of-pocket monthly cost will sink to $68.50.
51% : Medicare covered it for treating type 2 diabetes but not for weight loss, and it cost more than $1000 a month out-of-pocket.
49% : The Trump administration's November announcement would expand Medicare eligibility for GLP-1s and related medications to include obesity, perhaps as early as spring.
45% : Medicare should cover antiobesity drugs, many doctors argue.
43% : Then her Medicare plan notified her that it would no longer cover the drug.
40% : The bigger question is whether Medicare will amend its original 2003 regulations, which prohibit Part D coverage for weight-loss drugs.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.